{"name": "dornase alfa", "category": "drug", "content": "Dornase alfa, sold under the brand name Pulmozyme, is used for the treatment of cystic fibrosis. It is a recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA. Dornase alfa hydrolyzes the DNA present in sputum/mucus and reduces viscosity in the lungs, promoting improved clearance of secretions. It is produced in Chinese hamster ovary cells.   == Medical uses == Dornase alfa is indicated for the management of people with cystic fibrosis to improve pulmonary function.   == Society and culture ==   === Legal status === Dornase alfa is an orphan drug.   == Research == Dornase alfa has been shown to improve lung function in non-cystic fibrosis pre-term infants atelectasis.   == References =="}